​

CERo Therapeutics Ownership | Who Owns CERo Therapeutics?

OverviewFinancialsChart

CERo Therapeutics Ownership Summary

CERo Therapeutics is owned by 0.55% institutional investors, 4.13% insiders, and 95.33% retail investors.

CERO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCERo Therapeutics0.55%4.13%95.33%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20251025.00%156,980-36.39%-74.12%4-50.00%2-
Jun 30, 20258-246,771---8---

Recent Insider Transactions

DateNameRoleActivityValue
Dec 13, 2024YK Bioventures Opportunities GP I, LLC-Sell$179.93K
Dec 12, 2024YK Bioventures Opportunities GP I, LLC-Sell$113.02K
Dec 11, 2024YK Bioventures Opportunities GP I, LLC-Sell$107.50K
Dec 10, 2024YK Bioventures Opportunities GP I, LLC-Sell$141.39K
Dec 06, 2024YK Bioventures Opportunities GP I, LLC-Sell$148.42K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q2--
2025 Q1--
2024 Q4-7
2024 Q3--

CERO Ownership FAQ

Who Owns CERo Therapeutics?

CERo Therapeutics shareholders are primarily institutional investors at 0.55%, followed by 4.13% insiders and 95.32% retail investors. The average institutional ownership in CERo Therapeutics's industry, Biotech Stocks , is 35.75%, which CERo Therapeutics falls below.

Does Blackrock own CERo Therapeutics?

BlackRock is not among the top 10 institutional shareholders of CERo Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools